- Home
- SBGI vs NEO Comparison
SBGI vs NEO Comparison
Compare SBGI & NEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SBGI | NEO |
|---|---|---|
| Founded | 1986 | 2001 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Broadcasting | Precision Instruments |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.0B | 1.0B |
| IPO Year | 2023 | 2008 |
Fundamental Metrics
Financial Performance| Metric | SBGI | NEO |
|---|---|---|
| Price | $13.85 | $9.24 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 5 | 8 |
| Target Price | ★ $22.00 | $13.38 |
| AVG Volume (30 Days) | 391.7K | ★ 2.0M |
| Earning Date | 04-30-2026 | 04-28-2026 |
| Dividend Yield | ★ 6.56% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.28 | N/A |
| Revenue | ★ $3,169,000,000.00 | N/A |
| Revenue This Year | $12.37 | $10.63 |
| Revenue Next Year | N/A | $9.73 |
| P/E Ratio | $48.39 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $11.89 | $4.72 |
| 52 Week High | $17.88 | $13.74 |
Technical Indicators
Market Signals| Indicator | SBGI | NEO |
|---|---|---|
| Relative Strength Index (RSI) | 41.65 | 60.46 |
| Support Level | $13.39 | $7.42 |
| Resistance Level | $15.49 | $10.82 |
| Average True Range (ATR) | 0.52 | 0.40 |
| MACD | -0.11 | 0.04 |
| Stochastic Oscillator | 30.87 | 89.45 |
Price Performance
Historical ComparisonAbout SBGI Sinclair Inc.
Sinclair Inc. is the owner-operator of the second largest portfolio of television stations in the United States, with 185 full power stations in 86 markets, covering 40% of US households. Of the firm's roughly 600 channels, 150 are affiliated with the four national broadcasters—Fox, ABC, CBS, and NBC—with over 80 other channels aligned with The CW (Nexstar) and MyNetworkTV (Fox). Sinclair owns the Tennis Channel and stakes in Marquee Sports Network and YES Network, providing their premium sports content to pay-TV distributors.
About NEO NeoGenomics Inc.
NeoGenomics Inc provides oncology diagnostic testing and consultative services which include technical laboratory services and professional interpretation of laboratory test results by licensed physicians or molecular experts in pathology and oncology. The company operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. The company operates in a single segment and derives revenue from clients by providing clinical cancer testing, interpretation, and consultative services, molecular and NGS testing, comprehensive technical and professional services offerings, clinical trials and research, validation laboratory services, and oncology data solutions.